Lyophilized factor ix formulations

MA39779AUndetermined Publication Date: 2017-02-01BIOGEN MA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA39779
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2014-03-24
Filing Date
2015-03-24
Publication Date
2017-02-01
Patent Text Reader

Abstract

The present invention provides, among other things, pre-tyophilization formulations, reconstituted formulations, and lyophilate powder compositions comprising a factor ix (fix) polypeptide. The present invention also provides lyophilization methods for producing lyophilate powder comprising a fix polypeptide.The present invention is directed to a pre-tyophilization formulation comprising: (a) a factor ix (fix) polypeptide having fix coagulation activity; (b) a buffering agent; (c) a stabilizing agent; (d) a bulking agent; and (e) a surfactant, wherein the formulation has a fill volume of less than about 5 ml,and wherein each of (a) - (e) are at an amount per vial (mg / vial) sufficient to allow (1) improved stability of the fix polypeptide when lyophilized.
Need to check novelty before this filing date? Find Prior Art